檢索結果 - Nikhil Wagle

Refine Results
  1. 1
    Clinical Analysis and Interpretation of Cancer Genome Data

    Clinical Analysis and Interpretation of Cancer Genome Data 由 Eliezer M. Van Allen, Nikhil Wagle, Mia Levy

    出版 2013
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Biomarker-Based Prediction of Response to Therapy for Colorectal Cancer

    Biomarker-Based Prediction of Response to Therapy for Colorectal Cancer 由 Jeffrey S. Ross, Jorge Torres‐Mora, Nikhil Wagle, Timothy A. Jennings, David Jones

    出版 2010
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    ERK Mutations Confer Resistance to Mitogen-Activated Protein Kinase Pathway Inhibitors

    ERK Mutations Confer Resistance to Mitogen-Activated Protein Kinase Pathway Inhibitors 由 Eva M. Goetz, Mahmoud Ghandi, Daniel J. Treacy, Nikhil Wagle, Levi A. Garraway

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance

    MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance 由 Liam Cornell, Seth A. Wander, Tanvi H. Visal, Nikhil Wagle, Geoffrey I. Shapiro

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    A p53-Dependent Checkpoint Pathway Prevents Rereplication

    A p53-Dependent Checkpoint Pathway Prevents Rereplication 由 Cyrus Vaziri, Sandeep Saxena, Yesu Jeon, Charles Lee, Kazutaka Murata, Yuichi Machida, Nikhil Wagle, Deog Su Hwang, Anindya Dutta

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Rvb1p and Rvb2p Are Essential Components of a Chromatin Remodeling Complex That Regulates Transcription of over 5% of Yeast Genes

    Rvb1p and Rvb2p Are Essential Components of a Chromatin Remodeling Complex That Regulates Transcription of over 5% of Yeast Genes 由 Zophonı́as O. Jónsson, Suman Kumar Dhar, Geeta J. Narlikar, Roy Auty, Nikhil Wagle, David Pellman, Richard E. Pratt, Robert E. Kingston, Anindya Dutta

    出版 2001
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    A Genome-Scale RNA Interference Screen Implicates NF1 Loss in Resistance to RAF Inhibition

    A Genome-Scale RNA Interference Screen Implicates NF1 Loss in Resistance to RAF Inhibition 由 Steven R. Whittaker, Jean‐Philippe Theurillat, Eliezer M. Van Allen, Nikhil Wagle, Jessica Hsiao, Glenn S. Cowley, Dirk Schadendorf, David E. Root, Levi A. Garraway

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Prevalence and mutational determinants of high tumor mutation burden in breast cancer

    Prevalence and mutational determinants of high tumor mutation burden in breast cancer 由 Romualdo Barroso‐Sousa, Esha Jain, Ofir Cohen, D. Kim, Jorge E. Buendia-Buendia, Eric P. Winer, Nancy U. Lin, Sara M. Tolaney, Nikhil Wagle

    出版 2019
    獲取全文 獲取全文
    Pré-impressão
    加到收藏夾
    Saved in:
  9. 9
    Prevalence and mutational determinants of high tumor mutation burden in breast cancer

    Prevalence and mutational determinants of high tumor mutation burden in breast cancer 由 Romualdo Barroso‐Sousa, Esha Jain, Ofir Cohen, D. Kim, Jorge E. Buendia-Buendia, Eric P. Winer, Nancy U. Lin, Sara M. Tolaney, Nikhil Wagle

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia

    Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia 由 Andrew A. Lane, Oreofe O. Odejide, Nadja Kopp, Sunhee S. Kim, Akinori Yoda, Rachel Erlich, Nikhil Wagle, Gregory A. Abel, Scott J. Rodig, Joseph H. Antin, David M. Weinstock

    出版 2013
    獲取全文
    Carta
    加到收藏夾
    Saved in:
  11. 11
    Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma

    Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma 由 Benjamin M. Ellingson, Timothy F. Cloughesy, Thiri Zaw, Albert Lai, Phioanh L. Nghiemphu, Robert J. Harris, Shadi Lalezari, Nikhil Wagle, Kourosh M. Naeini, Jose Carrillo, Linda M. Liau, Whitney B. Pope

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling

    Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling 由 Nikhil Wagle, W. Marston Linehan, Michael F. Berger, Matthew J. Davis, Allison M. Sawyer, Panisa Pochanard, Sarah M. Kehoe, Cory M. Johannessen, Laura E. MacConaill, William C. Hahn, Matthew Meyerson, Levi A. Garraway

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing

    High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing 由 Nikhil Wagle, Michael F. Berger, Matthew J. Davis, Brendan Blumenstiel, Matthew DeFelice, Panisa Pochanard, Matthew D. Ducar, Paul Van Hummelen, Laura E. MacConaill, William C. Hahn, Matthew Meyerson, Stacey Gabriel, Levi A. Garraway

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

    A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma 由 Jonathan E. Rosenberg, Richard Bambury, Eliezer M. Van Allen, Harry A. Drabkin, Primo N. Lara, Andrea Harzstark, Nikhil Wagle, Robert A. Figlin, Gregory W. Smith, Levi A. Garraway, Toni K. Choueiri, Fredrik Erlandsson, Damian A. Laber

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies

    Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies 由 Utthara Nayar, Ofir Cohen, Christian Kapstad, Michael S. Cuoco, Adrienne G. Waks, Seth A. Wander, Corrie Painter, Samuel S. Freeman, Nicole S. Persky, Lori Marini, Karla Helvie, Nelly Oliver, Orit Rozenblatt–Rosen, X. Cynthia, Aviv Regev, Eric P. Winer, Nancy U. Lin, Nikhil Wagle

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer

    Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer 由 Sara M. Tolaney, Sally Tan, Hao Guo, William T. Barry, Eliezer M. Van Allen, Nikhil Wagle, Jane Brock, Katherine Larrabee, Cloud P. Paweletz, Elena Ivanova, Pasi A. Jänne, Beth Overmoyer, James R. Wright, Geoffrey I. Shapiro, Eric P. Winer, Ian E. Krop

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Oncogenic mutations in cervical cancer

    Oncogenic mutations in cervical cancer 由 Alexi A. Wright, Brooke E. Howitt, Andrea P. Myers, Suzanne E. Dahlberg, Emanuele Palescandolo, Paul Van Hummelen, Laura E. MacConaill, Melina Shoni, Nikhil Wagle, Robert T. Jones, Charles M. Quick, Anna Laury, Ingrid T. Katz, William C. Hahn, Ursula A. Matulonis, Michelle S. Hirsch

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer

    Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer 由 Yanan Kuang, Bilal A. Siddiqui, Jiani Hu, Matthew Pun, MacIntosh Cornwell, Gilles Buchwalter, Melissa E. Hughes, Nikhil Wagle, Paul Kirschmeier, Pasi A. Jänne, Cloud P. Paweletz, Nancy U. Lin, Ian E. Krop, William T. Barry, Eric P. Winer, Myles Brown, Rinath Jeselsohn

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Oncologists’ and cancer patients’ views on whole-exome sequencing and incidental findings: results from the CanSeq study

    Oncologists’ and cancer patients’ views on whole-exome sequencing and incidental findings: results from the CanSeq study 由 Stacy W. Gray, Elyse R. Park, Julie Najita, Yolanda Martins, Lara Traeger, Elizabeth F. Bair, Joshua J. Gagne, Judy E. Garber, Pasi A. Jänne, Neal I. Lindeman, Carol Lowenstein, Nelly Oliver, Lynette M. Sholl, Eliezer M. Van Allen, Nikhil Wagle, Sam Wood, Levi A. Garraway, Steven Joffe

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial

    Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial 由 Jorge Gómez Tejeda Zañudo, Romualdo Barroso‐Sousa, Esha Jain, Qingchun Jin, Tianyu Li, Jorge E. Buendia-Buendia, Alyssa Pereslete, Daniel L. Abravanel, Arlindo R. Ferreira, Eileen Wrabel, Karla Helvie, Melissa E. Hughes, Ann H. Partridge, Beth Overmoyer, Nancy U. Lin, Nabihah Tayob, Sara M. Tolaney, Nikhil Wagle

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: